Strategic Partnerships Taiba Healthcare actively partners with global pharma players and regional distributors, including recent collaboration with Advicenne Pharma, presenting opportunities for co-distribution, exclusive licenses, and regional market access in GCC and MENA.

Rare and Specialty Focus The company specializes in niche and rare disease medications, particularly hematology and metabolic disorders, with expansion potential in oncology, endocrinology, nephrology, and anti-infectives to broaden portfolio and cross-sell to hospital and specialty channels.

Regional footprint With operations across Oman, TaibaME and TaibaKSA, the group has established GCC market access and local presence, enabling faster adoption of specialty products and easier navigation of regulatory and distribution requirements.

Service Expansion Beyond pharmaceuticals Taiba offers hospital disposables, surgical and medical devices, and lab products, allowing cross-selling opportunities to hospitals and care facilities through a single regional partner.

Growth Readiness Revenue range indicates mid-market scale with potential for accelerated growth through strategic launches, early access programs, and expanded distribution agreements in MENA, supported by a track record of partnerships in the region.